Financial Advantage’s Pfizer PFE Stock Holding History

Financial Advantage’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-434	Closed	-$13K	–	139
2020 Q2	$13K	Buy	+434	New	+$14.7K	0.01%	111
2015 Q4	–	Sell	-87	Closed	-$3K	–	85
2015 Q3	$3K	Hold	87	–	–	﹤0.01%	100
2015 Q2	$3K	Hold	87	–	–	﹤0.01%	101
2015 Q1	$3K	Hold	87	–	–	﹤0.01%	120
2014 Q4	$3K	Hold	87	–	–	﹤0.01%	100
2014 Q3	$2K	Hold	87	–	–	﹤0.01%	119
2014 Q2	$2K	Hold	87	–	–	﹤0.01%	119
2014 Q1	$3K	Sell	87 -369	-81%	-$11K	﹤0.01%	121
2013 Q4	$13K	Hold	456	–	–	0.01%	129
2013 Q3	$12K	Hold	456	–	–	0.01%	120
2013 Q2	$12K	Buy	+456	New	+$12.6K	0.01%	125

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Financial Advantage's PFE Position: Q3 2020 in Review

Financial Advantage sold out of Pfizer (PFE) in Q3 2020, closing a stake of 434 shares — an estimated $13K sold.

Financial Advantage first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $13K in Q2 2020. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Financial Advantage reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Financial Advantage sold 434 Pfizer shares in Q3 2020, an estimated $13K.
Financial Advantage first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
Financial Advantage's Pfizer position peaked at $13K in Q2 2020.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Financial Advantage's 13F filing for Q3 2020, filed 27 Oct 2020.